This study is testing a combination of an experimental HIV vaccine and lab-made antibodies in people who already have HIV and are taking daily medication. The goal is to see if this combination can help the body control the virus on its own, allowing participants to safely take a…
Phase: PHASE1, PHASE2 • Sponsor: Boris Juelg, MD PhD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC